|
MechanismSPNS2 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Virginia Technologies, Inc.
0 Patents (Medical) associated with Virginia Technologies, Inc.
31 Dec 2025·International Journal of Sustainable Engineering
Outlook on human-centred design in industry 5.0: towards mass customisation, personalisation, co-creation, and co-production
Author: Ghotb, Salar ; Riggio, Mariapaola ; Hasani, Nastaran ; Hosseini, Abbas ; Hansen, Eric ; Nasir, Vahid ; Diederichs, Victoria ; Ashjazadeh, Yasaman
01 Sep 2025·Journal of Architectural Engineering
State of the Art: Shear Deflection Theory and Design for Wood Products
20 Jul 2025·Proceedings of the 31st ACM SIGKDD Conference on Knowledge Discovery and Data Mining V.1
MentorPDM: Learning Data-Driven Curriculum for Multi-Modal Predictive Maintenance
Author: Veeramani, Balaji ; Wang, Tuo ; Bowen, Edward ; Adams, Stephen ; Tiyyagura, Sunil Reddy ; Zhou, Dawei ; Zhang, Shuaicheng ; Bhattacharya, Sanmitra
100 Deals associated with Virginia Technologies, Inc.
100 Translational Medicine associated with Virginia Technologies, Inc.